The Netherlands has a long history as an international trading nation and was the first nation to establish a modern exchange in 1603. It's still one of the most active markets today, with over 22,000 deals with a value of USD2,226.6 billion completed over the past 30 years. The country is well known for contributions to technology and science – a legacy which continues with its high-profile life sciences and technology companies.
Our Netherlands team is ranked in the top ten of international law firms in the country, with over 80 lawyers and notaries working between our technology-focused Eindhoven office and our financial and regulatory focused Amsterdam office.
Comprehensive legal advice to German private bank Berenberg regarding the financing and the review of the borrower legal due diligence in connection with the development of the Hungarian solar park "Szügy" (65 MWp) of the international EPC & solar park developer Greencells Group, for which the Berenberg Green Energy Junior Debt Fund III provides junior debt financing for the construction and commissioning phase.
Competition and merger control law advice to REWE on various projects, among others on the acquisitions of coop and Lekkerland. REWE is one of the most important German trading and tourism companies, which we advise on various large-scale cross-border projects.
Press releaseREWE Group on provision of cross border regulatory advice relating to the acquisition of Lekkerland, a multinational wholesale and distributor business. The team advised on all regulatory issues including permits, EHS, dangerous goods and product related requirements such as the Tobacco Directive. The team also provided an in depth analysis of all affected jurisdictions (Austria, Belgium, Germany, the Netherlands, Spain, and Switzerland).
Press releaseSecret Escapes on the acquisition of Dutch based TravelBird, the online luxury and experience company, and Pigsback.com, the market leading marketplace in Ireland for online hospitality offers.
Press releaseHalyard Health on the sale of its surgical and infection prevention (S&IP) business to OMI.
Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
Latest news & insights
Work/Life - international employment news update
by Sean Nesbitt and Marc André Gimmy
Sustainability agreements between (potential) competitors
by Emma Kranendonk and Nick Strous
A regulator’s view on the AI Act | Tech Me Up! Session #6
Diablo Fatbike Infringes on KNAAP BIKES' Design Rights
by multiple authors
Work/Life: international employment news update
by multiple authors